Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
From paid studies for healthy volunteers to condition-specific trials, North Carolina offers a wide range of clinical research opportunities. Leading medical centers in Charlotte, Raleigh, and Durham are seeking participants, providing access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 2,450
Family Building Decision Support for Female Adolescent and Young Adult Cancer Survivors
for
Cancer Survivorship, Family Planning,
Location: Durham NC
Sponsor: Duke University
Sex: Female
Age: 18 - 39
Code: NCT07471685
Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Scarborough ME, Providence RI, Chicoutimi, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase3, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Saint John, Boston MA, Quebec, Stony Brook NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase3, Recruiting
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
for
Relapsed Small Cell Lung Cancer,
Location: Philadelphia PA, Salisbury NC, Pittsburgh PA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06681220
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
for
Dystonia
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Vima Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07304089
Phase2, Recruiting
CommunityRx-Kidney Health
for
Chronic Kidney Disease (Stages 1-4)
Location: Beulaville NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07237295
Recruiting
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
for
Liver Cirrhosis
Location: Morehead City NC, Miami Lakes FL, Charleston SC,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18 - 70+
Code: NCT07325526
Phase2, Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Philadelphia PA, Durham NC, Miami FL, Pittsburgh PA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Bryn Mawr PA, Syracuse NY, North Charleston SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
for
Diabetes Mellitus Type 2, Childhood-Onset
Location: Boston MA, Garden City NY, The Bronx NY, New York NY,
Sponsor: George Washington University
Sex: All
Age: 8 - 15
Code: NCT06525259
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Boston MA, Quebec, Sherbrooke, New York NY, Montreal,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase3, Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for
Lupus Erythematosus, Systemic
Location: Newark NJ, Voorhees Township NJ, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07438496
Phase3, Recruiting
Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma
for
Sarcoma Metastatic, Sarcoma, Soft Tissue
Location: Winston-Salem NC, Charlotte NC
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07291297
Phase2, Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Moncton, Quebec, New York NY, East Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase3, Recruiting
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
for
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer,
Location: Boston MA, Commack NY, Baltimore MD, Ottawa, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05123482
Phase1, Phase2, Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
for
Lymphoma, Malignant Solid Neoplasm
Location: Lake Success NY, Chesapeake VA, Newark DE, Scranton PA,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05006482
Phase3, Recruiting
Immersive Physical Therapy in the Neonatal Intensive Care Unit (NICU)
for
Physical Therapy, NICU Infants
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 0 - 70+
Code: NCT06927037
Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Stony Brook NY, Lake Success NY, Manhasset NY,